back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-09 13:46 Tx date 2024-10-08 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$56,000
+400,000 vol $0.14 each |
2,411,500 | |
| Filed 2023-12-12 12:40 Tx date 2023-12-08 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-200,000 vol |
2,011,500 | |
| Filed 2023-05-09 18:19 Tx date 2023-05-02 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,362
+1,071,500 vol $0.075 each |
2,211,500 | |
| Filed 2023-04-28 12:11 Tx date 2023-04-27 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-189,000
-300,000 vol $0.63 each |
1,140,000 | |
| Filed 2023-01-18 13:16 Tx date 2023-01-13 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
1,440,000 | |
| Filed 2022-03-04 17:41 Tx date 2021-06-30 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-145,655 vol |
540,000 | |
| Filed 2022-03-04 17:40 Tx date 2021-02-21 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-100,000 vol |
385,655 | |
| Filed 2022-03-04 17:38 Tx date 2022-03-01 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,040,000 | |
| Filed 2021-12-08 18:16 Tx date 2021-04-28 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
785,655 | |
| Filed 2020-12-17 18:15 Tx date 2020-12-09 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$154,000
+200,000 vol $0.77 each |
485,655 | |
| Filed 2020-09-10 00:10 Tx date 2020-09-04 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$450,073
+145,655 vol $3.09 each |
285,655 | |
| Filed 2020-09-10 00:09 Tx date 2020-06-29 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,260,000 vol |
140,000 | |
| Filed 2020-09-10 00:07 Tx date 2020-09-04 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+403,087 vol |
637,825 | |
| Filed 2020-09-10 00:04 Tx date 2020-06-29 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,112,646 vol |
234,738 | |
| Filed 2020-05-15 17:33 Tx date 2020-05-07 |
$BETR
BetterLife Pharma Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72,000
+400,000 vol $0.18 each |
1,400,000 | |
| Filed 2019-10-18 17:04 Tx date 2019-10-16 |
$PVOT
Pivot Pharmaceuticals Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$925.00
+5,000 vol $0.185 each |
2,347,384 | |
| Filed 2019-10-18 17:03 Tx date 2019-10-16 |
$PVOT
Pivot Pharmaceuticals Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+50,000 vol $0.19 each |
2,342,384 | |
| Filed 2019-03-25 Tx date 2019-03-25 |
$PVOT
Pivot Pharmaceuticals Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+200,000 vol $0.15 each |
||
| Filed 2019-03-25 Tx date 2019-03-25 |
$PVOT
Pivot Pharmaceuticals Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$30,000
+200,000 vol $0.15 each |
2,292,384 | |
| Filed 2018-01-26 Tx date 2013-06-27 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-100,000 vol |
0 | |
| Filed 2018-01-26 Tx date 2012-03-30 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-37,500 vol |
100,000 | |
| Filed 2018-01-26 Tx date 2012-03-30 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-12,500 vol |
137,500 | |
| Filed 2018-01-26 Tx date 2011-12-19 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2018-01-26 Tx date 2017-08-02 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-20,625
-12,500 vol $1.65 each |
0 | |
| Filed 2018-01-26 Tx date 2012-03-30 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+12,500 vol |
12,500 | |
| Filed 2018-01-26 Tx date 2011-12-19 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-26 Tx date 2011-06-28 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+100,000 vol $0.75 each |
150,000 | |
| Filed 2018-01-26 Tx date 2011-06-28 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+100,000 vol $0.75 each |
||
| Filed 2018-01-26 Tx date 2010-03-30 |
$
Merus Labs International Inc. |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2017-12-14 Tx date 2017-02-23 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+1,000,000 vol $0.70 each |
1,000,000 | |
| Filed 2017-12-14 Tx date 2010-12-26 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2017-11-06 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$36,029
+92,384 vol $0.39 each |
2,092,384 | |
| Filed 2017-12-14 Tx date 2015-04-21 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$200,000
+2,000,000 vol $0.10 each |
2,000,000 | |
| Filed 2017-12-14 Tx date 2010-12-26 |
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.) |
Ong, Moira Wi Ting
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|